A1 Refereed original research article in a scientific journal
Inter-patient variations of radiation-induced normal-tissue changes in Gd-EOB-DTPA-enhanced hepatic MRI scans during fractionated proton therapy
Authors: Richter C, Andronesi OC, Borra RJH, Voigt F, Lock S, Duda DG, Guimaraes AR, Hong TS, Bortfeld TR, Seco J
Publisher: ELSEVIER IRELAND LTD
Publication year: 2019
Journal: Clinical and Translational Radiation Oncology
Journal name in source: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
Journal acronym: CLIN TRANSL RAD ONCO
Volume: 18
First page : 113
Last page: 119
Number of pages: 7
eISSN: 2405-6308
DOI: https://doi.org/10.1016/j.ctro.2019.04.013
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/41308448
Background and purpose: Previous MRI studies have shown a substantial decrease in normal-tissue uptake of a hepatobiliary-directed contrast agent 6-9 weeks after liver irradiation. In this prospective clinical study, we investigated whether this effect is detectable during the course of proton therapy.Material and methods: Gd-EOB-DTPA enhanced MRI was performed twice during hypo-fractionated proton therapy of liver lesions in 9 patients (plus two patients with only one scan available). Dose-correlated signal changes were qualitatively scored based on difference images from the two scans. We evaluated the correlation between the MRI signal change with the planned dose map. The GTV was excluded from all analyses. In addition, were examined timing, irradiated liver volume, changes in liver function parameters as well as circulating biomarkers of inflammation.Results: Strong, moderate or no dose-correlated signal changes were detected for 2, 3 and 5 patients, respectively. Qualitative scoring was consistent with the quantitative dose to signal change correlation. In an exploratory analysis, the strongest correlation was found between the qualitative scoring and pretreatment IL-6 concentration. For all patients, a clear dose-correlated signal decrease was seen in late follow-up scans.Conclusion: Radiation-induced effects can be detected with Gd-EOB-DTPA enhanced MRI in a subgroup of patients within a few days after proton irradiation. The reason for the large inter-patient variations is not yet understood and will require validation in larger studies. (C) 2019 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.
Downloadable publication This is an electronic reprint of the original article. |  |
